Drug Approval | March 13, 2023
Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division
The company will be submitting the responses to US FDA observations within stipulated timeline
The company will be submitting the responses to US FDA observations within stipulated timeline
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Digital success is contingent on the way a company organizes itself around technology
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
Subscribe To Our Newsletter & Stay Updated
